Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02772549Active Not Recruiting

Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay

Role: lead

NCT05549635Recruiting

Database and Biobank of Patients With Hypersensitivity Pneumonitis

Role: lead

NCT02755441Active Not Recruiting

Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF

Role: lead

All 3 trials loaded